Skip to main content
. 2013 Oct 19;13(4):243–252. doi: 10.1007/s40268-013-0029-1

Table 2.

Exposure to study treatment (safety population—study eyes)

Number of eye days Besifloxacin, n (%) (N = 344) Vehicle, n (%) (N = 170)
≤6 8 (2.3 %) 5 (2.9 %)
7 332 (96.5 %) 164 (96.5 %)
8–11 4 (1.2 %) 1 (0.6 %)
≥12 0 0
Mean ± SD eye days 6.97 ± 0.39 6.92 ± 0.52